Hologic readies mid-range 4500 scanner
Like other bone densitometry vendors, Hologic is enjoying a banneryear, thanks to momentum created by Merck's Fosamax drug for thetreatment of osteoporosis. In addition to overall market growth,Hologic, of Waltham, MA, claims to have increased its market
Like other bone densitometry vendors, Hologic is enjoying a banneryear, thanks to momentum created by Merck's Fosamax drug for thetreatment of osteoporosis. In addition to overall market growth,Hologic, of Waltham, MA, claims to have increased its market sharein the segment to around 58%, compared with about 45% a year ago.
Hologic will try to build on its success by introducing a newmid-range member of its 4500 dual-energy x-ray absorptiometryfamily of bone measurement devices, according to Wade Fox, directorof marketing. Hologic developed the new system based on feedbackfrom clinicians, Fox said.
Hologic will also show its Sahara waterless ultrasound densitometer,which is not yet available in the U.S., as well as the mini C-armproduct line the company acquired through its purchase of Fluoroscanin August, Fox said.
Can Ultrasound-Based Radiomics Enhance Differentiation of HER2 Breast Cancer?
March 11th 2025Multicenter research revealed that a combined model of clinical factors and ultrasound-based radiomics exhibited greater than a 23 percent higher per patient-level accuracy rate for identifying HER2 breast cancer than a clinical model.
